Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of new-onset diabetes after kidney transplantation
ACTRN12614001171606Phase 4Not yet recruiting
- Sponsor
- Auckland District Health Board
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin in post-transplantation diabetes mellitus (PTDM) and prediabetes (2 arms), sponsored by Auckland District Health Board. Primary endpoints: Feasibility of recruitment, Tolerability of metformin and 1 more. Planned start Dec 2014; status: not yet recruiting.
02
Drugs
metformin
03
Conditions
post-transplantation diabetes mellitus (PTDM)prediabetes
Beyond the preview
Go deeper on ACTRN12614001171606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614001171606.